<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html>

<head>
    <title>Lilly</title>
    <meta http-equiv="content-type" content="text/html; charset=UTF-8">
    <link rel="stylesheet" type="text/css" href="fonts/stylesheet.css">
    <link rel="stylesheet" type="text/css" href="jquery.qtip.css">
    <link rel="stylesheet" type="text/css" href="site.css">
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.6.1/jquery.min.js" type="text/javascript"></script>
    <script src="jquery.qtip-1.0.0-rc3-dm.js" type="text/javascript"></script>
    <script src="jquery.bpopup-0.5.1.min.js" type="text/javascript"></script>
    <script src="site.js" type="text/javascript"></script>
    <script type="text/javascript">
            $(document).ready(function() {
                // Match all <A/> links with a title tag and use it as the content (default).
                $('a.tooltip[title]').qtip({
                    position: {
                        adjust: {
                            x: 5,
                            y: 10
                        },
                        corner: {
                            target: 'topRight',
                            tooltip: 'topLeft'
                        }
                    },
                    style: {
                        width: 150,
                        name: 'dark',
                        tip: {
                            corner: 'topLeft',
                            color: '#979797',
                            size: {
                                x: 9,
                                y: 10
                            }
                        }
                    }
                });
                $('a.bigtooltip[title]').qtip({
                    position: {
                        adjust: {
                            x: 5,
                            y: 10
                        },
                        corner: {
                            target: 'topRight',
                            tooltip: 'topLeft'
                        }
                    },
                    style: {
                        width: 236,
                        name: 'dark',
                        tip: {
                            corner: 'topLeft',
                            color: '#979797',
                            size: {
                                x: 9,
                                y: 10
                            }
                        }
                    }
                });
                $('a.bigtooltip_left[title]').qtip({
                    position: {
                        adjust: {
                            x: 0,
                            y: 10
                        },
                        corner: {
                            target: 'topLeft',
                            tooltip: 'topRight'
                        }
                    },
                    style: {
                        width: 580,
                        name: 'dark',
                        tip: {
                            corner: 'topRight',
                            color: '#979797',
                            size: {
                                x: 9,
                                y: 10
                            }
                        }
                    }
                });

                /*
									$('a.tooltip_under[title]').qtip({
										position: {
											corner: {
												target: 'bottomCenter',
												tooltip: 'bottomCenter'
											}
										},
										style: {
											width: 96,
											name: 'gray'
										}
									});

									$('a.bigtooltip_under[title]').qtip({
										position: {
											corner: {
												target: 'bottomCenter',
												tooltip: 'bottomCenter'
											}
										},
										style: {
											width: 191,
											name: 'gray'
										}
									});
									$('.molecule-container li a label').each(function(){
										if($(this).html().length < 20){
											$(this).parent().css('padding-top', '3px');
											$(this).parent().css('line-height', '32px');
											$(this).parent().css('height', '32px');
										}
									});
									*/
                $('a.bigtooltip_under').hover(function() {
                    $(this).addClass('hovered');
                }, function() {
                    $(this).removeClass('hovered');
                });
                $('a.tooltip_under').hover(function() {
                    $(this).addClass('hovered');
                }, function() {
                    $(this).removeClass('hovered');
                });
            });
        </script>
</head>

<body>
    <div id="browser_notice">
        This website is optimized for visualization with Firefox and Internet Explorer (8 or 9)
    </div>
    <div id="container">
        <div id="header">
            <img src="./img/header.png" alt="Lilly - Development Pipeline" />
        </div>
        <div id="content">
            <div id="content-left">

                <h1 class="DINBold">
                    <a href="index.html">Pipeline Overview</a>
                </h1>

                <div class="menu">
                    <h2 class="DINBold">View by Therapeutic Area</h2>
                    <ul>
                        <li>
                            <a href="7.html" class="" title="Cardiovascular">Cardiovascular</a>
                        </li>
                        <li>
                            <a href="8.html" class="" title="Diabetes">Diabetes</a>
                        </li>
                        <li>
                            <a href="13.html" class="" title="Emerging Markets">Emerging Markets</a>
                        </li>
                        <li>
                            <a href="14.html" class="" title="Immunology">Immunology</a>
                        </li>
                        <li>
                            <a href="9.html" class="" title="Musculoskeletal">Musculoskeletal</a>
                        </li>
                        <li>
                            <a href="10.html" class="" title="Neuroscience">Neuroscience</a>
                        </li>
                        <li>
                            <a href="11.html" class="active" title="Oncology">Oncology</a>
                        </li>
                    </ul>

                    <h2 class="DINBold">View by Molecule Type</h2>
                    <ul>
                        <li>
                            <a href="17.html" class="" title="Chemical entity (small)">Chemical entity (small)</a>
                        </li>
                        <li>
                            <a href="18.html" class="" title="Biologic entity (large)">Biologic entity (large)</a>
                        </li>
                    </ul>
                </div>

                <p>
                    <a>Pipeline movement since April 19, 2016</a>
                </p>
                <p>
                    <a>Pipeline data through<br/>July 19, 2016</a>
                </p>

            </div>
            <div id="content-center">
                <h1 class="big_h1">CLINICAL DEVELOPMENT
                    <span>PIPELINE</span>
                </h1>
                <div class="cells-container">
                    <div class="cells-container-inner">
                        <h1 class="toggle active">
                            <label class="exp_open"></label>
                            <span>Regulatory Review</span>
                        </h1>
                        <ul class="molecule-container">
                            <li id='cell-1' class='big '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-1" class="big bignme_cell bigtooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Olaratumab<br>
                                                            sarcoma</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup big" id="content-1">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Olaratumab (oh lar" a tue' mab)
                                        </div>
                                        <div class="molecule-position">
                                            <label>Regulatory Review</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY3012207 (olaratumab), a biologic entity, is a human IgG1 monoclonal antibody that binds to the platelet derived growth
                                        factor receptor alpha (PDGFRα) and blocks PDGFRα activation. LY3012207 is being studied
                                        for the treatment of advanced sarcoma.<br/><br>                                        For more information on olaratumab clinical studies, click
                                        <a href="https://clinicaltrials.gov/ct2/results?term=LY3012207" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                        <h1>
                                            <strong>PRESS RELEASES</strong> (1/1/2010-7/19/2016)
                                        </h1>
                                        <div>
                                            <p>
                                                <span style="color: #000000;">
                                                <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137556">
                                                    <span style="color: #000000;">Data In The Lancet Show Olaratumab Plus Doxorubicin Offered 11.8-Month Increase In Overall Survival In Patients With Advanced Soft Tissue Sarcoma, As Reported By Lilly And Memorial Sloan Kettering Researchers</span>
                                                </a>—June 9, 2016<br/><br/></span>
                                            </p>
                                            <p>
                                                <span style="color: #000000;">
                                                <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137539">
                                                    <span style="color: #000000;">FDA Grants Priority Review For Lilly's Olaratumab, An Investigational Medicine For Advanced Soft Tissue Sarcoma</span>
                                                </a>—May 4, 2016</span>
                                            </p>
                                        </div>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
                                $("#click-content-1").bind('click', function() {
                                    $("#content-1").bPopup();
                                    return false;
                                });
                            </script>
                            </li>
                            <li id='cell-2' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-3' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-4' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-5' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-6' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                        </ul>
                    </div>
                </div>

                <div class="cells-container">
                    <div class="cells-container-inner">
                        <h1 class="toggle active">
                            <label class="exp_open"></label>
                            <span>Phase III</span>
                        </h1>
                        <ul class="molecule-container">
                            <li id='cell-37' class='big '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-37" class="big bignme_cell bigtooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Abemaciclib<br>
                                                        metastatic breast
                                                    </br>
                                                    cancer</label>
                                                    <label class="toolt">NILEX</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup big" id="content-37">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Abemaciclib (a be muh sī klib)</div>
                                        <div class="molecule-position">
                                            <label>Phase III</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LLY2835219 (abemaciclib), a chemical entity, is a selective ATP-competitive inhibitor of cyclin dependent kinases (CDK) 4
                                        and 6 that inhibits phosphorylation of the Rb tumor suppressor protein and thereby
                                        induces G1 cell cycle arrest. LY2835219 is being studied for the treatment of metastatic
                                        breast cancer.
                                        <br/><br> For more information on LY2835219 clinical studies, click
                                        <a href="http://clinicaltrials.gov/ct2/results?term=LY2835219" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                        <h1>
                                            <span style="color: #000000;">
                                    <strong>PRESS RELEASES</strong>
                                    (1/1/2010-7/19/2016)</span>
                                        </h1>
                                        <p>
                                            <span style="color: #000000;">
                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137570">
                                        <span style="color: #000000;">Lilly And Boehringer Ingelheim Announce Clinical Trial Collaboration In Metastatic Breast Cancer</span>
                                            </a>—July 13, 2016<br/><br/></span>
                                        </p>
                                        <p>
                                            <span style="color: #000000;">
                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137549">
                                        <span style="color: #000000;">Lilly Announces Results From MONARCH 1 Trial Of Abemaciclib Monotherapy</span>
                                            </a>—June 3, 2016<br/><br/></span>
                                        </p>
                                        <p>
                                            <span style="color: #000000;">
                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137547">
                                        <span style="color: #000000;">Lilly Announces Webcast To Discuss Abemaciclib Data</span>
                                            </a>—May 31, 2016<br/><br/></span>
                                        </p>
                                        <p>
                                            <span style="color: #000000;">
                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137540">
                                        <span style="color: #000000;">ASCO Data Underscore Lilly's Diverse Oncology Pipeline And Portfolio</span>
                                            </a>—May 18, 2016<br/><br/></span>
                                        </p>
                                        <p>
                                            <span style="color: #000000;">
                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137472">
                                        <span style="color: #000000;">Lilly Receives FDA Breakthrough Therapy Designation For Abemaciclib - A CDK 4 And 6 Inhibitor - In Advanced Breast Cancer</span>
                                            </a>—October 8, 2015<br/><br/></span>
                                        </p>
                                        <p>
                                            <span style="color: #000000;">
                                    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137407">
                                        <span style="color: #000000;">Lilly Releases Early-Stage Pipeline Data At AACR Annual Meeting 2015</span>
                                            </a>—April 20, 2015<br/><br/></span>
                                        </p>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
                        $("#click-content-37").bind('click', function() {
                            $("#content-37").bPopup();
                            return false;
                        });
                    </script>
                            </li>
                            <li id='cell-38' class='big '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-38" class="big bignilex_cell bigtooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Abemaciclib
                                            <br>
                                            lung cancer</label>
                                                    <label class="toolt">NILEX</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup big" id="content-38">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Abemaciclib (a be muh sī klib)</div>
                                        <div class="molecule-position">
                                            <label>Phase III</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY2835219 (abemaciclib), a chemical entity, is a selective ATP-competitive inhibitor of cyclin dependent kinases (CDK) 4
                                        and 6 that inhibits phosphorylation of the Rb tumor suppressor protein and thereby
                                        induces G1 cell cycle arrest. LY2835219 is being studied for the treatment of KRAS
                                        mutant non small cell lung cancer.
                                        <br/><br> For more information on abemaciclib clinical studies, click
                                        <a href="http://clinicaltrials.gov/ct2/results?term=LY2835219" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                        <h1>
                                            <strong>PRESS RELEASES</strong> (1/1/2010-7/19/2016)
                                        </h1>
                                        <p>
                                            <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137407">Lilly Releases Early-Stage Pipeline Data At AACR Annual Meeting 2015</a>—April
                                            20, 2015<br/><br/>
                                            <a href="https://investor.lilly.com/releasedetail.cfm?ReleaseID=848054">Abemaciclib - Lilly's Oral CDK 4/6 Inhibitor - Shows Single-Agent Activity In A Phase I Study For Patients With A Specific Type Of Lung Cancer</a>                                            – May 12, 2014</p>
                                        <p></p>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
                $("#click-content-38").bind('click', function() {
                    $("#content-38").bPopup();
                    return false;
                });
            </script>
                            </li>
                            <li id='cell-39' class='big '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-39" class="big bignilex_cell bigtooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Ramucirumab<br>bladder cancer</label>
                                                    <label class="toolt">NILEX</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup big" id="content-39">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Ramucirumab (ra" mue sir' ue mab)</div>
                                        <div class="molecule-position">
                                            <label>Phase III</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY3009806 (ramucirumab), a biologic entity, is an antiangiogenic therapy. Specifically, it is a vascular endothelial growth
                                        factor (VEGF) Receptor 2 antagonist that binds and blocks activation of VEGF Receptor
                                        2 by blocking the binding of VEGF receptor ligands VEGF-A, VEGF-C, and VEGF-D. LY3009806
                                        is currently being studied for the treatment of second-line bladder cancer.
                                        <br/><br> For more information on ramucirumab clinical studies, click
                                        <a href="http://clinicaltrials.gov/ct2/results?term=LY3009806" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                        <h1>
                                            <strong>PRESS RELEASES</strong> (1/1/2010-7/19/2016)
                                        </h1>
                                        <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137466">Lilly's CYRAMZA® (Ramucirumab) Significantly Improves Progression-Free Survival In Phase II Bladder Cancer Trial</a>—September
                                        28, 2015<br/><br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
        $("#click-content-39").bind('click', function() {
            $("#content-39").bPopup();
            return false;
        });
    </script>
                            </li>
                            <li id='cell-40' class='big '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-40" class="big bignilex_cell bigtooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Ramucirumab
                            <br>
                            gastric cancer</label>
                                                    <label class="toolt">NILEX</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup big" id="content-40">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Ramucirumab (ra" mue sir' ue mab)</div>
                                        <div class="molecule-position">
                                            <label>Phase III</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY3009806 (ramucirumab), a biologic entity, is an antiangiogenic therapy. Specifically, it is a vascular endothelial growth
                                        factor (VEGF) Receptor 2 antagonist that binds and blocks activation of VEGF Receptor
                                        2 by blocking the binding of VEGF receptor ligands VEGF-A, VEGF-C, and VEGF-D. LY3009806
                                        is currently being studied for the treatment of first-line gastric cancer.
                                        <br/><br> For more information on ramucirumab clinical studies, click
                                        <a href="http://clinicaltrials.gov/ct2/results?term=LY3009806" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                        <h1>
                                            <strong>PRESS RELEASES</strong> (1/1/2010-7/19/2016)
                                        </h1>
                                        <div>
                                            <p>
                                                <span style="color: #000000;">
                <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137540">
                    <span style="color: #000000;">ASCO Data Underscore Lilly's Diverse Oncology Pipeline And Portfolio</span>
                                                </a>—May 18, 2016<br/><br/></span>
                                            </p>
                                            <span style="color: #000000;">
            <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137422">
                <span style="color: #000000;">Lilly To Present CYRAMZA® (Ramucirumab) Data At 2015 ASCO Annual Meeting</span>
                                            </a>—May 28, 2015</span><br/><br/><br/></div>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-40").bind('click', function() {
    $("#content-40").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-41' class='big '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-41" class="big bignilex_cell bigtooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Ramucirumab hepatocellular cancer</label>
                                                    <label class="toolt">NILEX</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup big" id="content-41">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Ramucirumab (ra" mue sir' ue mab)</div>
                                        <div class="molecule-position">
                                            <label>Phase III</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY3009806 (ramucirumab), a biologic entity, is an antiangiogenic therapy. Specifically, it is a vascular endothelial growth
                                        factor (VEGF) Receptor 2 antagonist that binds and blocks activation of VEGF Receptor
                                        2 by blocking the binding of VEGF receptor ligands VEGF-A, VEGF-C, and VEGF-D. LY3009806
                                        is currently being studied for the treatment of 2nd line hepatocellular carcinoma.
                                        <br/><br/> For more information on baricitinib clinical studies, click
                                        <a href="https://clinicaltrials.gov/ct2/results?term=LY3009806+hepatocellular&Search=Search" target="_blank">here</a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                        <h1>
                                            <strong>PRESS RELEASES</strong> (1/1/2010-7/19/2016)
                                        </h1>
                                        <div>
                                            <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137319">Lilly Announces Top-Line Results Of Phase III Hepatocellular Carcinoma Trial</a>—June
                                            11, 2014<br/><br/><br/></div>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-41").bind('click', function() {
    $("#content-41").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-42' class='big '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-42" class="big bignilex_cell bigtooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Ramucirumab<br>NSCLC</label>
                                                    <label class="toolt">NILEX</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup big" id="content-42">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Ramucirumab (ra" mue sir' ue mab)</div>
                                        <div class="molecule-position">
                                            <label>Phase III</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY3009806 (ramucirumab), a biologic entity, is an antiangiogenic therapy. Specifically, it is a vascular endothelial growth
                                        factor (VEGF) Receptor 2 antagonist that binds and blocks activation of VEGF Receptor
                                        2 by blocking the binding of VEGF receptor ligands VEGF-A, VEGF-C, and VEGF-D. LY3009806
                                        is currently being studied for the treatment of first-line, EGFR positive NSCLC.
                                        <br/><br> For more information on ramucirumab clinical studies, click
                                        <a href="http://clinicaltrials.gov/ct2/results?term=LY3009806" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                        <h1>
                                            <strong>PRESS RELEASES</strong> (1/1/2010-7/19/2016)
                                        </h1>
                                        <p></p>
                                        <p>
                                            <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137550">Early-Phase Immuno-Oncology Studies of Lilly's ALIMTA® (pemetrexed) and CYRAMZA® (ramucirumab) with Merck's KEYTRUDA® (pembrolizumab) Show Encouraging Results in Non-Small Cell Lung Cancer</a>—June
                                            5, 2016</p>
                                        <p>
                                            <span style="color: #000000;" data-mce-mark="1">
    <a href="http://lilly.mediaroom.com/index.php?s=9042&item=137540">
        <span style="color: #000000;" data-mce-mark="1"><br/>ASCO Data Underscore Lilly's Diverse Oncology Pipeline And Portfolio</span>
                                            </a>—May 18, 2016</span><br/><br/></p>
                                        <span style="color: #000000;">
<a href="http://lilly.mediaroom.com/index.php?s=9042&item=137422">
    <span style="color: #000000;">Lilly To Present CYRAMZA® (Ramucirumab) Data At 2015 ASCO Annual Meeting</span>
                                        </a>—May 28, 2015</span><br/><br/>
                                        <span style="color: #000000;">
<a href="http://lilly.mediaroom.com/index.php?s=9042&item=137426">
    <span style="color: #000000;">Lilly, Merck Enter Collaboration Agreement To Research Immuno-Oncology Combination Regimens In Multiple Types Of Cancer</span>
                                        </a>—January 13, 2015</span>
                                        <p>
                                            <span style="color: #000000;" data-mce-mark="1"></span>
                                        </p>
                                        <p></p>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-42").bind('click', function() {
    $("#content-42").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-43' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-44' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-45' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-46' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-47' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-48' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-49' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-50' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-51' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-52' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-53' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-54' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                        </ul>
                    </div>
                </div>

                <div class="cells-container">
                    <div class="cells-container-inner">
                        <h1 class="toggle active">
                            <label class="exp_open"></label>
                            <span>Phase II</span>
                        </h1>
                        <ul class="molecule-container">
                            <li id='cell-55' class='big '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-55" class="big bignme_cell bigtooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Prexasertib<br>cancer</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup big" id="content-55">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Prexasertib (prex” a ser’ tib)</div>
                                        <div class="molecule-position">
                                            <label>Phase II</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY2606368 monomesylate monohydrate (formerly known as Chk1 inhibitor) is a chemical entity that preferentially binds to and
                                        inhibits checkpoint kinase 1 (Chk1), a global regulator of the mammalian cell cycle
                                        and, to a lesser extent, inhibits Chk2. LY2606368 monomesylate monohydrate is being
                                        studied for the treatment of cancer.<br/><br>                                        For more information on LY2606368 clinical studies, click
                                        <a href="http://clinicaltrials.gov/ct2/results?term=LY2606368" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-55").bind('click', function() {
    $("#content-55").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-56' class='big '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-56" class="big bignme_cell bigtooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>CXCR4 pept antag<br>
    cancer</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup big" id="content-56">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">CXCR4 Peptide Antagonist</div>
                                        <div class="molecule-position">
                                            <label>Phase II</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY2510924 (CXCR4 peptide antagonist) is a biologic entity that antagonizes ligand binding to the CXC chemokine receptor 4.
                                        LY2510924 is being studied for the treatment of cancer.<br/><br>                                        For more information on LY2510924 clinical studies, click
                                        <a href="http://clinicaltrials.gov/ct2/results?term=LY2510924" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-56").bind('click', function() {
    $("#content-56").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-57' class='big '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-57" class="big bignme_cell bigtooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Emibetuzumab<br>cancer</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup big" id="content-57">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Emibetuzumab (em” i be tooz’ ue mab)</div>
                                        <div class="molecule-position">
                                            <label>Phase II</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY2875358 (formerly known as c-Met antibody), a biologic entity, was designed as a bivalent c-Met antibody that has neutralization
                                        and internalization activity with minimal agonistic activity. LY2875358 is being
                                        studied for the treatment of NSCLC.
                                        <br/><br> For more information on LY2875358 clinical studies, click
                                        <a href="http://clinicaltrials.gov/ct2/results?term=LY2875358" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-57").bind('click', function() {
    $("#content-57").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-58' class='big '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-58" class="big bignme_cell bigtooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>FGF receptor inh
<br>
cancer</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup big" id="content-58">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">FGF Receptor Inhibitor</div>
                                        <div class="molecule-position">
                                            <label>Phase II</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY2874455 (FGF receptor inhibitor), a chemical entity, inhibits autophosphorylation of fibroblast growth factor (FGF) receptors
                                        1, 2, 3 and 4, which is required for activation of FGF-induced downstream signaling.
                                        LY2874455 is being studied for the treatment of cancer.<br/><br>                                        For more information on LY2874455 clinical studies, click
                                        <a href="http://clinicaltrials.gov/ct2/results?term=LY2874455" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-58").bind('click', function() {
    $("#content-58").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-59' class='big '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-59" class="big bignme_cell bigtooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Galunisertib<br>cancer</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup big" id="content-59">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Galunisertib (gal ue” ni ser’ tib)</div>
                                        <div class="molecule-position">
                                            <label>Phase II</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY2157299 monohydrate (formerly known as TGFb R1 kinase inhibitor) is a chemical entity that selectively blocks transforming
                                        growth factor-β receptor I kinase and TGF-b signaling. LY2157299 monohydrate is being
                                        studied for the treatment of pancreatic and hepatocellular cancer.
                                        <br/><br> For more information on LY2157299 clinical studies, click
                                        <a href="http://clinicaltrials.gov/ct2/results?term=LY2157299" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-59").bind('click', function() {
    $("#content-59").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-60' class='big '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-60" class="big bignme_cell bigtooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Merestinib
<br>
cancer</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup big" id="content-60">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Merestinib cancer (mer es’ ti nib)</div>
                                        <div class="molecule-position">
                                            <label>Phase II</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY2801653 (formerly known as c-Met inhibitor) is a chemical entity that has been shown in vitro to be a reversible type II
                                        ATP-competitive inhibitor of MET, a receptor for hepatocyte growth factor. Preclinical
                                        testing also has shown LY2801653 to inhibit several other receptor tyrosine oncokinases
                                        including MST1R, FLT3, AXL, MERTK, TEK, ROS1, and DDR1/2 and the serine/threonine
                                        kinases MKNK1/2. LY2801653 is being studied for the treatment of cancer.
                                        <br/><br> For more information on LY2801653 clinical studies, click
                                        <a href="http://clinicaltrials.gov/ct2/results?term=LY2801653" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-60").bind('click', function() {
    $("#content-60").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-61' class='big '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-61" class="big bignme_cell bigtooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>NOTCH inhibitor<br>
cancer</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup big" id="content-61">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">NOTCH inhibitor cancer</div>
                                        <div class="molecule-position">
                                            <label>Phase II</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY3039478 (NOTCH Inhibitor) is a new chemical entity being studied for the treatment of cancer.<br/><br>                                        For more information on LY3039478 clinical studies, click
                                        <a href="https://clinicaltrials.gov/ct2/results?term=LY3039478&Search=Search" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-61").bind('click', function() {
    $("#content-61").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-62' class='big '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-62" class="big bignme_cell bigtooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>PI3 kinase/<br>mTOR dual inh<br>cancer</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup big" id="content-62">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">PI3 Kinase/mTOR Dual Inhibitor</div>
                                        <div class="molecule-position">
                                            <label>Phase II</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY3023414 (PI3 Kinase/mTOR dual Inhibitor) is a chemical entity being studied for the treatment of prostate cancer and NSCLC.
                                        <br/><br> For more information on LY3023414 clinical studies, click
                                        <a href="https://clinicaltrials.gov/ct2/results?term=LY3023414&Search=Search" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-62").bind('click', function() {
    $("#content-62").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-63' class='big '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-63" class="big bignme_cell bigtooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Ralimetinib
<br>cancer</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup big" id="content-63">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Ralimetinib (ral’’ i me’ ti nib)</div>
                                        <div class="molecule-position">
                                            <label>Phase II</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY2228820 dimesylate (formerly known as p38 MAP kinase inhibitor) is a chemical entity that preferentially binds to and inhibits
                                        p38 MAP kinase. LY2228820 dimesylate is being studied for the treatment of ovarian
                                        cancer.<br/><br> For more information on
                                        LY2228820 dimesylate clinical studies, click
                                        <a href="http://clinicaltrials.gov/ct2/results?term=LY2228820" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>

                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-63").bind('click', function() {
    $("#content-63").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-64' class='big '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-64" class="big bignilex_cell bigtooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Abemaciclib<br>squamous NSCLC</label>
                                                    <label class="toolt">NILEX</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup big" id="content-64">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Abemaciclib (a be muh sī klib)</div>
                                        <div class="molecule-position">
                                            <label>Phase II</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        LY2835219 (abemaciclib), a chemical entity, is a selective ATP-competitive inhibitor of cyclin dependent kinases (CDK) 4
                                        and 6 that inhibits phosphorylation of the Rb tumor suppressor protein and thereby
                                        induces G1 cell cycle arrest. LY2835219 is being studied for the treatment of squamous
                                        NSCLC.

                                        <br/><br> For more information on LY2835219 clinical studies, click
                                        <a href="https://clinicaltrials.gov/ct2/results?term=LY2835219&Search=Search" target="_blank">here</A>.</u>
                                        </a><br/>
                                        <br>
                                        <p style="font-size:10px;">
                                            NOTE: If you click on the link above it will take you to a site maintained by a third party, which is solely responsible
                                            for its content.</p>
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-64").bind('click', function() {
    $("#content-64").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-65' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-66' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-67' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-68' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-69' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-70' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-71' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-72' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-73' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-74' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-75' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-76' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-77' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-78' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-79' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-80' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-81' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-82' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-83' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-84' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-85' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-86' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-87' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-88' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-89' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-90' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                        </ul>
                    </div>
                </div>

                <div class="cells-container">
                    <div class="cells-container-inner">
                        <h1 class="toggle active">
                            <label class="exp_open"></label>
                            <span>Phase I</span>
                        </h1>
                        <ul class="molecule-container">
                            <li id='cell-91' class='big '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-91" class="big bignme_cell bigtooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Angiopoietin 2<br>MAb<br>cancer</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup big" id="content-91">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Angiopoietin 2 MAb cancer</div>
                                        <div class="molecule-position">
                                            <label>Phase I</label>
                                            <label>Business area: Research</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        "Angiopoietin 2 Antibody" is a new biologic entity being studied for the treatment of cancer.
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-91").bind('click', function() {
    $("#content-91").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-92' class='big '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-92" class="big bignme_cell bigtooltip_under" title="CLICK FOR MORE"><img class="minfoimg" align="absmiddle" src="./img/bigachived_milestone_molecule.png"
                                                    alt="" />
                                                <div class="molecule-inner-content">
                                                    <label>Chk1 inhibitor cancer</label>
                                                    <label class="toolt">New Molecular Entity
</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup big" id="content-92">
                                    <div class="molecule-title">

                                        <div class="minfobg"><img src="./img/bigachived_milestone_molecule.png" alt="" /></div>

                                        <div class="mtitle DINBold">Chk1 Inhibitor</div>
                                        <div class="molecule-position">
                                            <label>Phase I</label>
                                            <label>Business area: Oncology</label>
                                            <label style='display:block;'>Molecule That Achieved Milestone
</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        "Chk1 Inhibitor" is a new chemical entity being studied for the treatment of cancer. Molecule is owned by a 3rd party, Lilly
                                        retains rights.
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-92").bind('click', function() {
    $("#content-92").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-93' class='big '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-93" class="big bignme_cell bigtooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>CSF-1R MAb<br>
cancer</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup big" id="content-93">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">CSF-1R Monoclonal Antibody</div>
                                        <div class="molecule-position">
                                            <label>Phase I</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        "CSF-1R Monoclonal Antibody" is a new biologic entity being studied for the treatment of cancer.
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-93").bind('click', function() {
    $("#content-93").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-94' class='big '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-94" class="big bignme_cell bigtooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>FGFR3-ADC<br>cancer</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup big" id="content-94">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">FGFR3-ADC cancer</div>
                                        <div class="molecule-position">
                                            <label>Phase I</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        "FGFR3-ADC" is a new biologic entity being studied for the treatment of cancer.
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-94").bind('click', function() {
    $("#content-94").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-95' class='big '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-95" class="big bignme_cell bigtooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Met/EGFR Bispecific Antibody
<br>cancer</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup big" id="content-95">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Met/EGFR Bispecific Antibody</div>
                                        <div class="molecule-position">
                                            <label>Phase I</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        "Met/EGFR Bispecific Antibody" is a new biologic entity being studied for the treatment of cancer.
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-95").bind('click', function() {
    $("#content-95").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-96' class='big '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-96" class="big bignme_cell bigtooltip_under" title="CLICK FOR MORE">
                                                <div class="molecule-inner-content">
                                                    <label>Pan-Raf<br>inhibitor
<br>cancer</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup big" id="content-96">
                                    <div class="molecule-title">

                                        <div class="mtitle DINBold">Pan-Raf inhibitor</div>
                                        <div class="molecule-position">
                                            <label>Phase I</label>
                                            <label>Business area: Oncology</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        "Pan-Raf inhibitor" is a new chemical entity being studied for the treatment of cancer.
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-96").bind('click', function() {
    $("#content-96").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-97' class='big '>
                                <table cellspacing="0" cellpadding="0">
                                    <tr>
                                        <td>
                                            <a id="click-content-97" class="big bignme_cell bigtooltip_under" title="CLICK FOR MORE"><img class="minfoimg" align="absmiddle" src="./img/bigachived_milestone_molecule.png"
                                                    alt="" />
                                                <div class="molecule-inner-content">
                                                    <label>PD-L1 MAb
<br>
cancer</label>
                                                    <label class="toolt">New Molecular Entity</label>
                                                    <label class="click_for_more">Click for more</label>
                                                </div>
                                            </a>
                                        </td>
                                    </tr>
                                </table>

                                <div class="content-popup big" id="content-97">
                                    <div class="molecule-title">

                                        <div class="minfobg"><img src="./img/bigachived_milestone_molecule.png" alt="" /></div>

                                        <div class="mtitle DINBold">PD-L1 Antibody</div>
                                        <div class="molecule-position">
                                            <label>Phase I</label>
                                            <label>Business area: Oncology</label>
                                            <label style='display:block;'>Molecule That Achieved Milestone
</label>
                                        </div>
                                    </div>

                                    <div class="molecule-description">
                                        "PD-L1 Antibody" is a new biologic entity being studied for the treatment of cancer.
                                        <br/><br/>
                                    </div>
                                    <a class="bClose">&nbsp;</a>
                                </div>
                                <script type="text/javascript">
$("#click-content-97").bind('click', function() {
    $("#content-97").bPopup();
    return false;
});
</script>
                            </li>
                            <li id='cell-98' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-99' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-100' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-101' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-102' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-103' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-104' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-105' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-106' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-107' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-108' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-109' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-110' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-111' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-112' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-113' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-114' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-115' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-116' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-117' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-118' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-119' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-120' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-121' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-122' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-123' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-124' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-125' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                            <li id='cell-126' class='big empty'>
                                <span class="big bigempty_cell no_bg">&nbsp;</span>
                            </li>
                        </ul>
                    </div>

                </div>

                <div class="disclaimer">
                    <b>Pipeline Disclaimer</b><br/>The information included on this site reflects Eli Lilly and Company's
                    clinical development pipeline and is not intended for promotional purposes. It includes both new molecular
                    entities as well as select new indications or line extensions of currently-approved products, that are
                    in clinical development. There are significant risks and uncertainties in pharmaceutical research and
                    development. Scientific and regulatory hurdles may cause pipeline molecules to be discontinued, delayed
                    or fail to reach the market. There can be no guarantee that pipeline molecules will receive regulatory
                    approval or that they will prove to be commercially successful. Information is current as of July 19,
                    2016. Lilly assumes no duty to update this information.
                    <br><br> For competitive reasons, some pipeline molecules are not identified; in those instances, only
                    the therapeutic area in which the molecule is being studied is listed.</div>
                <p class="footer">
                    Property of Eli Lilly and Company.
                </p>
            </div>
            <div id="content-right">

                <div class="molecule-info2">
                    <h1>Legend</h1>
                    <a href="full_legend.html">
                        <div class="molecule-data"><img class="fl" align="absmiddle" src="./img/new_molecule.png" alt="" />
                            <div class="molecule-text">New Molecule</div>
                        </div>
                    </a>
                    <a href="full_legend.html">
                        <div class="molecule-data"><img class="fl" align="absmiddle" src="./img/achived_milestone_molecule.png" alt="" />
                            <div class="molecule-text">Molecule That Achieved Milestone
                            </div>
                        </div>
                    </a>
                    <a href="full_legend.html">
                        <div class="molecule-data"><img class="fl" align="absmiddle" src="./img/scientific_name_given.png" alt="" />
                            <div class="molecule-text">Nonproprietary Name Granted</div>
                        </div>
                    </a>
                    <a href="full_legend.html">
                        <div class="molecule-data"><img class="fl" align="absmiddle" src="./img/later_phase_molecule.png" alt="" />
                            <div class="molecule-text">Molecule Moved to Earlier Phase</div>
                        </div>
                    </a>
                    <a href="full_legend.html">
                        <div class="molecule-data"><img class="fl" align="absmiddle" src="./img/lost_molecule.png" alt="" />
                            <div class="molecule-text">Lost Through Attrition</div>
                        </div>
                    </a>
                    <a href="full_legend.html">
                        <div class="molecule-data"><img class="fl" align="absmiddle" src="./img/checked.png" alt="" />
                            <div class="molecule-text">Regulatory Approval Achieved</div>
                        </div>
                    </a>
                    <div class="molecule-data">
                        *Commercial Collaboration
                    </div>
                </div>
                <ul class="molecule-info">
                    <li>
                        <span class="nme_cell">
<b>NME</b>
</span>
                    </li>

                    <li>
                        <span class="nilex_cell">
<b>Select NILEX</b>
</span>
                    </li>

                    <li>
                        <span class="diagnostic_cell">
<b>Diagnostic</b>
</span>
                    </li>
                </ul>
                <div id="full_legend_link">
                    For more information about Lilly's interactive pipeline website,
                    <a href="full_legend.html">click here</a>
                </div>
            </div>
        </div>
        <div id="footer"></div>
    </div>

    <script type="text/javascript">
$(window).load(function() {
    var cCenterHeight = $('#content-center').height();
    var cLeftHeight = $('#content-left').height();
    var paddingTop = cCenterHeight - cLeftHeight - 10;
    if (paddingTop > 0) {
        //$('.footer').css('padding-top', parseInt(paddingTop)+'px');
    }
    $('.molecule-container').each(function() {

        if (!$(this).has('li').length) {
            $(this).css('padding', '0');
        }

        $(this).find('a.big').each(function() {

            var a_height = $(this).height();

            var label_height = $(this).find('label').height();
            if (label_height != 0) {
                $(this).find('label').css('padding-top', parseInt(((a_height - label_height) / 2) - 5));
            } else {
                $(this).find('label').css('padding-top', 12);
            }
        });

    });
    //Set default open/close settings $('.molecule-container').hide(); //Hide/close all containers $('.cells-container-inner h1:last').addClass('active').next().hide();

});
</script>

    <script type="text/javascript">
$(document).ready(function() {
    // align text in center
    $('.molecule-info2 .molecule-data').each(function() {
        var molecule_text_height = $(this).children('.molecule-text').height();
        if (molecule_text_height < 23) {
            $(this).children('.molecule-text').css('padding-top', (23 - molecule_text_height) / 2);
        }
    });
    //On Click
    $('.cells-container-inner h1.toggle').click(function() {
        if ($(this).hasClass('active')) {
            $(this).toggleClass('active').next().slideUp(); //Add "active" state to clicked trigger and slide down the immediate next container
            $(this).children('label').toggleClass('exp_open');
        } else {
            $(this).toggleClass('active').next().slideDown(); //Add "active" state to clicked trigger and slide down the immediate next container
            $(this).children('label').toggleClass('exp_open');
        }
        return false; //Prevent the browser jump to the link anchor
    });
    $('.molecule-container').each(function() {
        var i = 0;
        var j = 0;
        var a = new Array(3);
        $(this).find('li').each(function() {
            if ($(this).hasClass('empty')) {
                a[i] = $(this);
                j++;
            }
            i++;
            if (j == 3) {
                for (var k = 0; k < 3; k++) {
                    a[k].remove();
                }
            }
            if (i == 3) {
                i = 0;
                j = 0;
            }
        });
    });
});
</script>
    <!-- START OF SmartSource Data Collector TAG -->
    <!-- Copyright (c) 1996-2010 WebTrends Inc.  All rights reserved. -->
    <!-- Version: 9.3.0 -->
    <!-- Tag Builder Version: 3.1  -->
    <!-- Created: 2/10/2011 5:17:20 PM -->
    <script src="webtrends.js" type="text/javascript"></script>
    <!-- ----------------------------------------------------------------------------------- -->
    <!-- Warning: The two script blocks below must remain inline. Moving them to an external -->
    <!-- JavaScript include file can cause serious problems with cross-domain tracking.      -->
    <!-- ----------------------------------------------------------------------------------- -->
    <script type="text/javascript">
        //<![CDATA[
var _tag = new WebTrends();
_tag.dcsGetId();

        //]]>
</script>
    <script type="text/javascript">
        //<![CDATA[
_tag.dcsCustom = function() {
    // Add custom parameters here. _tag.DCSext.param_name=param_value;
}
_tag.dcsCollect();

        //]]>
</script>
    <noscript>
        <div><img alt="DCSIMG" id="DCSIMG" width="1" height="1" src="http://statse.webtrendslive.com/dcskykqjqvz5bd05pjea7z15r_7k3s/njs.gif?dcsuri=/nojavascript&amp;WT.js=No&amp;WT.tv=9.3.0&amp;WT.dcssip=www.lilly.com,lilly.com,elilly.com"
            /></div>
    </noscript>
    <!-- END OF SmartSource Data Collector TAG -->
</body>

</html>